OncoMed Presents Data on Clinical and Preclinical Anti-Cancer Stem Cell … – GlobeNewswire (press release)
Nasdaq |
OncoMed Presents Data on Clinical and Preclinical Anti-Cancer Stem Cell …
GlobeNewswire (press release) PHILADELPHIA and REDWOOD CITY, Calif., April 21, 2015 (GLOBE NEWSWIRE) — OncoMed Pharmaceuticals, Inc. (Nasdaq:OMED), a clinical-stage company developing novel therapeutics that target cancer stem cells (CSCs), or tumor-initiating cells, today … OncoMed Down on Phase Ib Lung Cancer Study Data OncoMed Announces Abstracts Accepted for Presentation at the 2015 ASCO … |
